HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seung-Mo Hong Selected Research

Somatostatin Receptors (Somatostatin Receptor)

1/2024Somatostatin receptor 2 (SSTR2) expression is associated with better clinical outcome and prognosis in rectal neuroendocrine tumors.
12/2021A Case of Glomus Tumor Mimicking Neuroendocrine Tumor on 68 Ga-DOTATOC PET/CT.
2/2016Prognostic Value of Somatostatin Receptor Subtypes in Pancreatic Neuroendocrine Tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Seung-Mo Hong Research Topics

Disease

117Neoplasms (Cancer)
03/2024 - 07/2005
44Adenocarcinoma
02/2024 - 07/2006
39Pancreatic Neoplasms (Pancreatic Cancer)
02/2024 - 02/2009
27Carcinoma (Carcinomatosis)
04/2024 - 07/2005
18Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2024 - 10/2013
10Neoplasm Metastasis (Metastasis)
01/2023 - 06/2010
9Carcinogenesis
10/2023 - 10/2006
9Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 04/2016
8Cholangiocarcinoma
06/2020 - 11/2012
8Hepatocellular Carcinoma (Hepatoma)
01/2020 - 12/2014
7Lymphatic Metastasis
01/2024 - 08/2010
6Rectal Neoplasms (Rectal Cancer)
03/2022 - 10/2012
5Colonic Neoplasms (Colon Cancer)
01/2023 - 01/2014
5Neoplasms, Cystic, Mucinous, and Serous
07/2022 - 10/2011
4Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2021 - 10/2019
3Disease Progression
02/2024 - 05/2018
3Cysts
01/2022 - 01/2014
3Pancreatic Cyst
01/2022 - 01/2011
3Gallbladder Neoplasms (Gallbladder Cancer)
12/2021 - 05/2008
3Microsatellite Instability
01/2021 - 03/2017
3Margins of Excision
11/2020 - 01/2017
3Parkinson Disease (Parkinson's Disease)
01/2019 - 02/2016
3Primitive Neuroectodermal Tumors (PNET)
09/2018 - 02/2016
3Fibrosis (Cirrhosis)
01/2017 - 02/2012
2Melanoma (Melanoma, Malignant)
09/2023 - 10/2016
2Adenoma (Adenomas)
01/2023 - 10/2017
2Ovarian Neoplasms (Ovarian Cancer)
07/2022 - 01/2022
2Epithelioid Hemangioendothelioma
03/2021 - 12/2016
2Mucinous Adenocarcinoma (Mucinous Carcinoma)
06/2019 - 02/2013
2Virus Diseases (Viral Diseases)
02/2019 - 12/2018
2Autoimmune Pancreatitis
08/2017 - 05/2015
2Ulcerative Colitis
08/2017 - 12/2013

Drug/Important Bio-Agent (IBA)

33Proteins (Proteins, Gene)FDA Link
01/2023 - 09/2005
24Biomarkers (Surrogate Marker)IBA
01/2024 - 05/2008
10Indicators and Reagents (Reagents)IBA
01/2023 - 06/2008
8MucinsIBA
09/2023 - 01/2013
7Cadherins (E-Cadherin)IBA
01/2023 - 07/2010
7GemcitabineFDA Link
01/2021 - 08/2010
7DNA (Deoxyribonucleic Acid)IBA
07/2017 - 09/2008
6ChromatinIBA
01/2024 - 01/2012
6Formaldehyde (Formol)FDA Link
03/2020 - 01/2014
6ParaffinIBA
03/2020 - 01/2014
5SynaptophysinIBA
03/2024 - 07/2005
5MicroRNAs (MicroRNA)IBA
02/2012 - 02/2009
4ChromograninsIBA
03/2024 - 07/2005
4folfirinoxIBA
02/2024 - 01/2018
4dibenzyldithiocarbamate (DBDC)IBA
12/2023 - 01/2019
4Peptides (Polypeptides)IBA
07/2023 - 07/2017
4CateninsIBA
01/2023 - 01/2011
4Eosine Yellowish-(YS) (Eosin)IBA
12/2022 - 01/2020
4Messenger RNA (mRNA)IBA
09/2019 - 10/2006
3Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2024 - 01/2019
3Somatostatin Receptors (Somatostatin Receptor)IBA
01/2024 - 02/2016
3Circulating Tumor DNAIBA
10/2023 - 02/2014
3Chromogranin AIBA
09/2023 - 11/2020
3Calcibiotic Root Canal SealerIBA
01/2023 - 01/2015
3Phenobarbital (Luminal)FDA Link
01/2023 - 02/2012
3Hematoxylin (Haematoxylon)IBA
01/2022 - 01/2020
3Cisplatin (Platino)FDA LinkGeneric
01/2021 - 10/2017
3Bile Pigments (Bilin)IBA
09/2020 - 06/2007
3DesminIBA
01/2020 - 01/2015
3AntigensIBA
12/2018 - 01/2017
3ErbB Receptors (EGF Receptor)IBA
04/2016 - 08/2004
3MethyltransferasesIBA
05/2014 - 02/2010
3DecitabineFDA Link
01/2012 - 02/2010
2Colloids (Colloid)IBA
04/2024 - 10/2013
2somatostatin receptor 2IBA
01/2024 - 02/2016
2Cyclin D1IBA
10/2023 - 08/2010
2Peptide Hormones (Polypeptide Hormones)IBA
07/2023 - 05/2015
2Serotonin (5 Hydroxytryptamine)IBA
07/2023 - 10/2013
2Moxifloxacin (Avelox)FDA Link
01/2023 - 11/2022
2N-acetyltalosaminuronic acid (NAT)IBA
12/2022 - 09/2022
2Ethanol (Ethyl Alcohol)IBA
01/2022 - 09/2018
2Carrier Proteins (Binding Protein)IBA
01/2022 - 01/2012
2EnzymesIBA
01/2021 - 08/2015
2Fluorouracil (Carac)FDA LinkGeneric
10/2020 - 01/2017
2lanreotide (Somatuline)FDA Link
06/2020 - 01/2019
2Keratin-19 (Keratin 19)IBA
01/2020 - 01/2015
2AntibodiesIBA
01/2020 - 01/2020
2alpha-SynucleinIBA
01/2019 - 02/2016
2SynucleinsIBA
01/2019 - 07/2018
2CytokinesIBA
12/2018 - 08/2017
2VimentinIBA
05/2018 - 01/2015
2Phosphotransferases (Kinase)IBA
12/2017 - 06/2010
2Cell Adhesion MoleculesIBA
05/2017 - 01/2011
2Telomerase (Telomerase Reverse Transcriptase)IBA
03/2017 - 10/2011

Therapy/Procedure

23Therapeutics
02/2024 - 05/2008
11Drug Therapy (Chemotherapy)
01/2022 - 08/2015
6Chemoradiotherapy
03/2022 - 10/2012
5Immunotherapy
09/2023 - 01/2020
5Radiotherapy
10/2020 - 08/2010
4Adjuvant Chemotherapy
01/2024 - 01/2017
4Neoadjuvant Therapy
12/2022 - 10/2020
4Liver Transplantation
02/2022 - 01/2017
4Pancreaticoduodenectomy
01/2019 - 09/2011
3Pancreatectomy
03/2019 - 02/2012
2Gastrectomy
01/2022 - 12/2021
2Hepatectomy
03/2021 - 12/2016
2Lasers (Laser)
01/2020 - 02/2012
2Operative Surgical Procedures
02/2016 - 10/2012